Pharmaceutical pricing and access are like water in that they seek the fastest path. Countries like Australia and New Zealand have consistently dammed that path over many decades, primarily to divert the water, slow it down, and give themselves time to secure the lowest prices. Is the US on the verge of shutting off the water?
We can't moan about another country doing what we've been doing for decades
October 12, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
PYC to present early polycystic kidney disease trial data at US nephrology conference
October 7, 2026 - - Australian Biotech -
CSL raises US$1.5 billion from US bond investors to refinance debt
October 7, 2026 - - Latest News -
Every serious attempt to reform PBS pricing has run into the same problem
October 7, 2026 - - Latest News -
AFT reaffirms profit guidance as its R&D pipeline moves toward 2029 launches
October 7, 2026 - - Latest News -
The patient who knows what they want is informed and not a danger
October 7, 2026 - - Latest News -
TGA turns to national security surveillance platform to police therapeutic goods compliance
October 6, 2026 - - Latest News -
Company size shapes CEO pay trends in Australian health care and biotechnology
October 6, 2026 - - Latest News
